Company Ticker News January 11, 2022Biogen stock falls more than 6% after Medicare plans coverage limits for pricy Alzheimer's drug 0 0 Share
Company Ticker News January 11, 2022Biogen Inc. (BIIB) CEO Michel Vounatsos on JPMorgan 40th Annual Healthcare Conference (Transcript) 0 0 Share
Company Ticker News January 10, 2022Medicare told to reassess premium hike after price slashed on Biogen Alzheimer's drug 0 0 Share
Company Ticker News January 5, 2022Why Biogen Inc. (BIIB) is Poised to Beat Earnings Estimates Again 0 0 Share
Company Ticker News January 5, 2022Biogen (BIIB) Opts for In-Licensing SMA Therapy From Ionis 0 0 Share
Company Ticker News January 4, 2022Why Biogen's Alzheimer's drug Aduhelm is so controversial 0 0 Share
Press Release January 4, 2022Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA 0 0 Share
Press Release January 4, 2022Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA 0 0 Share
